Bankole A. Johnson

Bankole A. Johnson is a declared insider of Adial Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 13 filings cover trades dated from 31 July 2018 to 4 October 2021.

On the open market, the record shows 5 purchases worth €214k and 4 sales worth €807k. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. In 2021 alone, the filings show no purchases and 2 sales.

A typical purchase (the median) is worth €50k. Across 4 purchases, this insider has always bought alone, with no colleague buying within 30 days.

Most recently, on 6 October 2021, the filings show an open-market sale in Adial Pharmaceuticals, Inc. The clock since the last published purchase (1 April 2019) now reads 2,779 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.